F6300

Flumazenil

>99% (HPLC), solid, benzodiazepine receptor antagonist

• Synonym(e): Ro 15-1788, Ro15-1788
• Empirische Formel (Hill-System): C₁₅H₁₄FN₃O₃
• CAS-Nummer: 78755-81-4
• Molekulargewicht: 303.29
• MDL-Nummer: MFCD00242764
• UNSPSC-Code: 12352200
• PubChem Substanz-ID: 24278437
• NACRES: NA.77

Eigenschaften

• product name: Flumazenil, >99% (HPLC), solid
• Assay: >99% (HPLC)
• Form: solid
• Farbe: white
• Ersteller: Roche
• Lagertemp.: 2-8°C
• SMILES String: CCOC(=O)c1ncn-2c1CN(C)C(=O)c3cc(F)ccc-23
• InChI: 1S/C15H14FN3O3/c1-3-22-15(21)13-12-7-18(2)14(20)10-6-9(16)4-5-11(10)19(12)8-17-13/h4-6,8H,3,7H2,1-2H3
• InChIKey: OFBIFZUFASYYRE-UHFFFAOYSA-N
• Angaben zum Gen: human ... BZRAP1(9256) , GABRA1(2554) , GABRA2(2555) , GABRA3(2556) , GABRA4(2557) , GABRA5(2558) , GABRA6(2559) , GABRB1(2560) , GABRB2(2561) , GABRB3(2562) , GABRD(2563) , GABRE(2564) , GABRG1(2565) , GABRG2(2566) , GABRG3(2567) , GABRP(2568) , GABRQ(55879) ; rat ... Gabra2(29706) , Gabrg1(140674)

Beschreibung

Allgemeine Beschreibung

Flumazenil reverses sedative and hypnotic effects of benzodiazepines. It is used to increase acquisition, enhance retention and treat amnesia in mice.

Biochem./physiol. Wirkung

Highly specific benzodiazepine receptor antagonist.

Leistungsmerkmale und Vorteile

This compound is a featured product for Neuroscience research. Click here to discover more featured Neuroscience products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.

This compound is featured on the GABAA Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by Roche. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 2
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable
• Persönliche Schutzausrüstung: Eyeshields, Gloves, type N95 (US)